Literatur
Nach Information von Roche
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
red EU-Zulassung für Obinutuzumab bei CLL. Info Onkol. 17, 55 (2014). https://doi.org/10.1007/s15004-014-0916-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-014-0916-9